FKACX
Price
$32.31
Change
-$0.40 (-1.22%)
Updated
Jun 13 closing price
Net Assets
4.51B
RGAHX
Price
$77.22
Change
-$0.93 (-1.19%)
Updated
Jun 13 closing price
Net Assets
306.22B
Interact to see
Advertisement

FKACX vs RGAHX

Header iconFKACX vs RGAHX Comparison
Open Charts FKACX vs RGAHXBanner chart's image
Franklin Growth Opportunities C
Price$32.31
Change-$0.40 (-1.22%)
VolumeN/A
Net Assets4.51B
American Funds Growth Fund of Amer R5E
Price$77.22
Change-$0.93 (-1.19%)
VolumeN/A
Net Assets306.22B
FKACX vs RGAHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FKACX vs. RGAHX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FKACX is a Buy and RGAHX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 306B vs. FKACX (4.51B). RGAHX pays higher dividends than FKACX: RGAHX (0.50) vs FKACX (0.00). FKACX was incepted earlier than RGAHX: FKACX (26 years) vs RGAHX (10 years). FKACX (1.66) is less costly to investors than RGAHX (0.44). FKACX is a more actively managed with annual turnover of: 27.49 vs. RGAHX (25.00). RGAHX has a lower initial minimum investment than FKACX: RGAHX (250) vs FKACX (1000). RGAHX annual gain was more profitable for investors over the last year : 7.38 vs. FKACX (-6.59). RGAHX return over 5 years is better than : 49.84 vs. FKACX (-5.99).
FKACXRGAHXFKACX / RGAHX
Total Expense Ratio1.660.44377%
Annual Report Gross Expense Ratio1.660.44377%
Fund Existence26 years10 years-
Gain YTD0.8745.14717%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets4.51B306B1%
Annual Yield % from dividends0.000.50-
Returns for 1 year-6.597.38-89%
Returns for 3 years16.7753.8531%
Returns for 5 years-5.9949.84-12%
Returns for 10 years8.20N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PHX4.33N/A
N/A
PHX Minerals
ESE184.00-2.44
-1.31%
ESCO Technologies
CRL149.45-2.44
-1.61%
Charles River Laboratories International
STOK11.53-0.29
-2.45%
Stoke Therapeutics
SHPH0.13-0.01
-9.35%
Shuttle Pharmaceuticals Holdings Inc